Publication: Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of Lonafarnib-boosted with Ritonavir with or without Peginterferon Alfa in patients with chronic hepatitis delta
Program
KU-Authors
KU Authors
Co-Authors
Etzion, Ohad
Hamid, Saeed Sadiq
Asselah, Tarik
Gherlan, George Sebastian
Turcanu, Adela
Petrivna, Tsarynna
Weissfeld, Lisa
Choong, Ingrid
Hislop, Colin
Apelian, David
Advisor
Publication Date
Language
en
Type
Journal Title
Journal ISSN
Volume Title
Abstract
N/A
Source:
Journal of Hepatology
Publisher:
Elsevier
Keywords:
Subject
Gastroenterology and hepatology